One platform. Multiple conditions. Intelligent care.
Cardiometabolic conditions are complex, interconnected, and require consistent management. Welldoc is an AI healthcare leader dedicated to streamlining this vital care through a rigorous, innovative model backed by research and real-world application.
Healthcare-ready AI that supports chronic conditions and beyond
.avif)
One platform. Multiple conditions.
Diabetes & hypertension
FDA-cleared** AI solution for individuals to manage their type 1 and type 2 diabetes, and other comorbidities like hypertension.
Weight management with or without GLP-1s
A complete solution across the weight-loss and obesity management journey, with or without GLP-1 medication.
Specialty
conditions
Beyond cardiometabolic care, Welldoc addresses chronic kidney disease, MASH, diabetes in pregnancy, and can easily expand to support broader immunology, rare, and neurological conditions.
Welldoc is where healthcare technology finally connects
Care management made easy

Built for the GLP-1 era and beyond
.avif)
Support for mental and emotional well-being
Stress, sleep, and mental well-being function are interconnected with cardiometabolic health, not isolated issues. The Welldoc platform seamlessly integrates tools that help individuals reframe thinking, develop coping strategies, and support holistic well-being, addressing these often-overlooked factors that directly impact physical health.
.avif)
Constantly evolving. Continuously connecting healthcare.

As technology, research, and conditions evolve, so do we.
As an AI innovator in healthcare, we believe the best healthcare solutions are on the horizon. By building on our established clinical rigor and regulatory expertise, we’re shifting our focus from reactive monitoring to personalized, proactive insights, giving you trustworthy, responsible, and scalable tech that anticipates needs, motivates, engages, and helps build better and more sustainable habits.
We don't just adapt to healthcare's evolution; we help shape it alongside you.
Explore the future of cardiometabolic health
Book a demo and reach out to connect with the Welldoc sales team today.
.png)
.avif)
1. Welldoc Data on File. Results may vary based on Welldoc App adherence.
2. Quinn, C.C. Shardell, M.D. Terrin, M.L. Barr, E.A. Ballew, S.H. Gruber-Baldini, A.L. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011 Sep;34(9):1934-42. Erratum in: Diabetes Care. 2013 Nov;36(11):3850.
3. Kumbara A, Iyer A, Shomali M. Blood pressure improvement in people using a digital health solution for comprehensive diabetes self-management. Poster presented at: 16th Annual Cardiometabolic Health Congress; October 14-17, 2021; National Harbor, MD.
*Results may vary based on program design.
**Welldoc® Diabetes and Welldoc Diabetes Rx is an FDA-cleared medical device, intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. The other Welldoc App products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.